These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24535068)

  • 21. [VVI mode cardiac pacing: cause or risk factor of cerebral embolism?].
    Lascault G; Dürr A; Juillard JB; Thomas D; Frank R; Gautier JC; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1527-31. PubMed ID: 1300952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing.
    Zanini R; Facchinetti AI; Gallo G; Cazzamalli L; Bonandi L; Dei Cas L
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2076-9. PubMed ID: 1704596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of ventricular demand and dual-chamber pacing models on the long-term clinical outcome and cardiac remodeling in patients with symptomatic bradycardia].
    Dong YX; Guo M; Yang YZ; Gao LJ; Cha YM; Xie ZZ; Zhang SL; Sun YH; Wang YQ; Xia YL; Boodhna J
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(30):2103-7. PubMed ID: 22093984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities.
    Sgarbossa EB; Pinski SL; Maloney JD; Simmons TW; Wilkoff BL; Castle LW; Trohman RG
    Circulation; 1993 Sep; 88(3):1045-53. PubMed ID: 8353866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode.
    Brandt J; Anderson H; Fåhraeus T; Schüller H
    J Am Coll Cardiol; 1992 Sep; 20(3):633-9. PubMed ID: 1512343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers.
    Loring Z; North R; Hellkamp AS; Atwater BD; Frazier-Mills CG; Jackson KP; Pokorney SD; Lamas GA; Piccini JP
    Pacing Clin Electrophysiol; 2020 Dec; 43(12):1461-1466. PubMed ID: 33085123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of atrial thrombus formation and atrial appendage function in patients with pacemaker by transesophageal echocardiography.
    Alizadeh A; Maleki M; Bassiri H; Alasti M; Emkanjoo Z; Haghjoo M; Arya A; Bagherzadeh A; Fazelifar A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1251-4. PubMed ID: 17100679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical remodeling of the atria following loss of atrioventricular synchrony: a long-term study in humans.
    Sparks PB; Mond HG; Vohra JK; Jayaprakash S; Kalman JM
    Circulation; 1999 Nov; 100(18):1894-900. PubMed ID: 10545434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices.
    Sulke N; Dritsas A; Bostock J; Wells A; Morris R; Sowton E
    Br Heart J; 1992 Jan; 67(1):57-64. PubMed ID: 1739528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial arrhythmias in dual chamber pacing and their influence on long-term mortality.
    Detollenaere M; van Wassenhove E; Jordaens L
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):1846-50. PubMed ID: 1279559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of changes in stroke volume on QT dispersion during long-term DDD and VVI pacing].
    Lelakowski J; Majewski J; Bednarek J; Szczepkowski J; Machejek J
    Przegl Lek; 2001; 58(3):111-6. PubMed ID: 11475854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing.
    Linde-Edelstam C; Nordlander R; Pehrsson SK; Rydén L
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):905-15. PubMed ID: 1376903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of DDD pacing in patients with an implantable cardioverter defibrillator.
    Geelen P; Lorga Filho A; Chauvin M; Wellens F; Brugada P
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):177-81. PubMed ID: 9121985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of VVI pacing on P-wave dispersion in patients with dual-chamber pacemakers.
    Amasyali B; Köse S; Aytemir K; Can I; Kabakci G; Tokgozoglu L; Ozkutlu H; Nazli N; Isik E; Oto A
    Heart Vessels; 2006 Jan; 21(1):8-12. PubMed ID: 16440142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of the P wave at implantation for atrial fibrillation after VVI pacemaker implantation.
    Snoeck J; Decoster H; Vrints C; Marchand X; Kahn JC; Verherstraeten M; Berkhof M; Franque L
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2077-83. PubMed ID: 1279603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study.
    Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M;
    Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.